Patent · US Active

Noninvasive diagnosis of fetal aneuploidy by sequencing

US8195415B2 · kind B2 · utility

320Cited by
143References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 29, 2010
Grant dateJun 5, 2012
Priority date
Expiry dateJan 29, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/387
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Disclosed is a method to achieve digital quantification of DNA (i.e., counting differences between identical sequences) using direct shotgun sequencing followed by mapping to the chromosome of origin and enumeration of fragments per chromosome. The preferred method uses massively parallel sequencing, which can produce tens of millions of short sequence tags in a single run and enabling a sampling that can be statistically evaluated. By counting the number of sequence tags mapped to a predefined window in each chromosome, the over- or under-representation of any chromosome in maternal plasma DNA contributed by an aneuploid fetus can be detected. This method does not require the differentiation of fetal versus maternal DNA. The median count of autosomal values is used as a normalization constant to account for differences in total number of sequence tags is used for comparison between samples and between chromosomes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.